tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RemeGen Co., Ltd. Announces Successful AGM and Shareholder Meeting Results
Company AnnouncementsRemeGen Co., Ltd. Announces Successful AGM and Shareholder Meeting Results
11d ago
9995
RemeGen Partners with Vor Biopharma for Global Expansion of Telitacicept
PremiumCompany Announcements
RemeGen Partners with Vor Biopharma for Global Expansion of Telitacicept
11d ago
9995
RemeGen Co., Ltd. Completes Successful Placement of H Shares
PremiumCompany Announcements
RemeGen Co., Ltd. Completes Successful Placement of H Shares
1M ago
9995
RemeGen’s Telitacicept Gains Approval for Myasthenia Gravis Treatment in China
PremiumCompany Announcements
RemeGen’s Telitacicept Gains Approval for Myasthenia Gravis Treatment in China
1M ago
9995
RemeGen Co., Ltd. Announces 2024 AGM with Key Resolutions
PremiumCompany Announcements
RemeGen Co., Ltd. Announces 2024 AGM with Key Resolutions
1M ago
9995
RemeGen Co., Ltd. Announces Strategic Governance Changes at 2025 Shareholder Meeting
PremiumCompany AnnouncementsRemeGen Co., Ltd. Announces Strategic Governance Changes at 2025 Shareholder Meeting
1M ago
9995
RemeGen Co., Ltd. Enhances Governance with New Remuneration Committee
Premium
Company Announcements
RemeGen Co., Ltd. Enhances Governance with New Remuneration Committee
1M ago
9995
RemeGen Co., Ltd. Proposes Amendments to Enhance Corporate Governance
Premium
Company Announcements
RemeGen Co., Ltd. Proposes Amendments to Enhance Corporate Governance
1M ago
9995
RemeGen Co., Ltd. Updates Nomination Committee to Enhance Governance
PremiumCompany Announcements
RemeGen Co., Ltd. Updates Nomination Committee to Enhance Governance
1M ago
9995
RemeGen Co., Ltd. Announces Board Composition and Roles
PremiumCompany Announcements
RemeGen Co., Ltd. Announces Board Composition and Roles
1M ago
9995
RemeGen Co., Ltd. Strengthens Governance with New Audit Committee
PremiumCompany Announcements
RemeGen Co., Ltd. Strengthens Governance with New Audit Committee
1M ago
9995
RemeGen Co., Ltd. Enhances Corporate Governance with New Nomination Committee
PremiumCompany Announcements
RemeGen Co., Ltd. Enhances Corporate Governance with New Nomination Committee
1M ago
9995
RemeGen Co., Ltd. Announces New H Shares Placement to Raise HK$806 Million
PremiumCompany AnnouncementsRemeGen Co., Ltd. Announces New H Shares Placement to Raise HK$806 Million
2M ago
9995
RemeGen’s Disitamab Vedotin Approved for Advanced Breast Cancer Treatment in China
Premium
Company Announcements
RemeGen’s Disitamab Vedotin Approved for Advanced Breast Cancer Treatment in China
2M ago
9995
RemeGen Co., Ltd. Releases 2025 Q1 Financial Report
Premium
Company Announcements
RemeGen Co., Ltd. Releases 2025 Q1 Financial Report
2M ago
9995
RemeGen Co., Ltd. Schedules Board Meeting to Review Q1 2025 Results
PremiumCompany Announcements
RemeGen Co., Ltd. Schedules Board Meeting to Review Q1 2025 Results
3M ago
9995
RemeGen Co., Ltd. Announces New Executive Director Appointment
PremiumCompany Announcements
RemeGen Co., Ltd. Announces New Executive Director Appointment
3M ago
9995
RemeGen Co., Ltd. Announces Board Composition and Leadership Roles
PremiumCompany Announcements
RemeGen Co., Ltd. Announces Board Composition and Leadership Roles
3M ago
9995
RemeGen Co., Ltd. Reports Strong 2024 Revenue Growth and Pipeline Advancements
PremiumCompany Announcements
RemeGen Co., Ltd. Reports Strong 2024 Revenue Growth and Pipeline Advancements
3M ago
9995
RemeGen’s Telitacicept Study Gains Spotlight at 2025 AAN Meeting
PremiumCompany AnnouncementsRemeGen’s Telitacicept Study Gains Spotlight at 2025 AAN Meeting
4M ago
9995
RemeGen Co., Ltd. Schedules Board Meeting to Review Annual Results and Dividend Consideration
Premium
Company Announcements
RemeGen Co., Ltd. Schedules Board Meeting to Review Annual Results and Dividend Consideration
4M ago
9995
RemeGen Co., Ltd. Announces 2025 EGM to Appoint New Executive Director
Premium
Company Announcements
RemeGen Co., Ltd. Announces 2025 EGM to Appoint New Executive Director
4M ago
9995

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >